Powerful weight-loss drugs are expanding use of US health care as patients starting prescriptions are diagnosed with ...

The obesity treatment market is dominated by Eli Lilly and Novo Nordisk, making it challenging for Viking. Read why I ...

Eli Lilly and Novo Nordisk will kick off a massive shopping spree in 2025. The two obesity giants will be sitting on cash ...

(THE CONVERSATION) Cerebrospinal fluid, or CSF, is a clear, colorless liquid that plays a crucial role in maintaining the health and function of your central nervous system. It cushions the brain and ...

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers.

Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

2024 was one of the most eventful years for the pharmaceutical, biotech, life sciences and medical marketing industries.

The FDA is slated to reveal Thursday whether Eli Lilly’s supply of its obesity drug Zepbound can meet U.S. demand. The decision will have major implications both for Lilly and its competitor Novo ...

In a public health breakthrough, U.S. obesity rates have decreased for the first time in more than a decade, with new weight loss medications potentially playing a role in the ...

The Left tends to blame our lack of universal health coverage for this downtrend. But our lagging life expectancy is largely ...

Researchers have discovered a new population of neurons that is responsive to the hormone leptin. Leptin responsive neurons are important in obesity since leptin is sent to the brain from the body's ...

On its own, obesity can cause acute ailments, including breathlessness and back pain. Worse, it often leads to other chronic ...